On Aug. 21, 2019, Pfizer announced that it is investing an additional half billion-dollars for the construction of its state-of-the-art gene therapy manufacturing facility in Sanford, NC. The facility will support Pfizer s continuing investment in gene therapy R&D, similar to Pfizer s ChapelOriginal Article
You may also like
Nouscom to present re‑treatment data in Lynch...
ViiV Healthcare to unveil new HIV treatment data at...
Almirall’s paediatric registration of Ebglyss for...
The Bloc appoints Jon Chapman as European Executive...
Early Genomic Indicators of Praziquantel Resistance in...
Flu Virus Interaction with Host Cell Machinery Mapped...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.